We are live on ! Find out more
QTTB icon

Q32 Bio
QTTB

83 hedge funds and large institutions have $38.4M invested in Q32 Bio in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 27 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

443% more call options, than puts

Call options by funds: $114K | Put options by funds: $21K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.13% less ownership

Funds ownership: 2.45% → 2.32% (-0.13%)

5% less funds holding

Funds holding: 87 → 83 (-4)

23% less capital invested

Capital invested by funds: $49.9M → $38.4M (-$11.5M)

29% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 14

44% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 27

Holders
83
Holders Change
-4
Holders Change %
-4.6%
% of All Funds
1.43%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
15
Reduced
27
Closed
14
Calls
$114K
Puts
$21K
Net Calls
+$93K
Net Calls Change
+$1.16M

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$295K
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$266K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$266K
4
BCM
Bridgeway Capital Management
Texas
+$227K
5
Bank of America
Bank of America
North Carolina
+$143K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$889K
2
JP Morgan Chase
JP Morgan Chase
New York
-$667K
3
Millennium Management
Millennium Management
New York
-$595K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$443K
5
UBS Group
UBS Group
Switzerland
-$355K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of Montreal
76
Bank of Montreal
Ontario, Canada
$265 +$266K +6,531 New
D.E. Shaw & Co
77
D.E. Shaw & Co
New York
– -$443K -12,503 Closed
Group One Trading
78
Group One Trading
Illinois
– -$224K -5,481 Closed
CSS
79
Cubist Systematic Strategies
Connecticut
– -$55K -1,563 Closed
B
80
Bailard
California
– -$47K -1,319 Closed
Assenagon Asset Management
81
Assenagon Asset Management
Luxembourg
– -$40K -1,119 Closed
VF
82
Virtu Financial
New York
– -$34K -965 Closed
HF
83
HRT Financial
New York
– -$28K -800 Closed
Commonwealth Equity Services
84
Commonwealth Equity Services
Massachusetts
– -$20K -588 Closed
Legal & General Group
85
Legal & General Group
United Kingdom
– -$7K -186 Closed
CAPTRUST Financial Advisors
86
CAPTRUST Financial Advisors
North Carolina
– -$3K -78 Closed
Baillie Gifford & Co
87
Baillie Gifford & Co
United Kingdom
– -$1K -27 Closed
New York State Common Retirement Fund
88
New York State Common Retirement Fund
New York
– -$1K -20 Closed
APC
89
Aspire Private Capital
North Carolina
– -$612 -15 -47%
SOW
90
State of Wyoming
Wyoming
– +$163 +4 New
1 2 3
4

QTTB Hedge Fund Activity: Q3 2022 in Review

83 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q3 2022, worth a combined $38.4M — down 23% from $49.9M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of QTTB and 10 opened new positions — a net loss of 4 holders — while 27 trimmed existing stakes and 15 added.

The largest buyer was Renaissance Technologies, adding an estimated $295K. The largest seller was Fidelity Investments, cutting an estimated $889K.

  • 83 institutional investors held Q32 Bio (QTTB) as of Q3 2022, down from 87 in Q2 2022.
  • Funds reported $38.4M of Q32 Bio stock for Q3 2022, down 23% quarter-over-quarter.
  • 10 funds opened new Q32 Bio positions in Q3 2022 and 14 closed out, a net change of -4 holders.
  • The largest Q32 Bio buyer in Q3 2022 was Renaissance Technologies, an estimated $295K added.
  • The largest Q32 Bio seller in Q3 2022 was Fidelity Investments, an estimated $889K sold.

Based on aggregated 13F filings for Q3 2022.